EGFR and cancer: Abnormal activation of the epidermal-growth-factor receptor (EGFR) is due to either its overexpression or mutation, which mediates downstream-signaling overactivation and becomes an important driver of the malignant development of human cancers, including lung, head-and-neck, and brain cancers [6,7].